eXoZymes, Inc.

NASDAQ:EXOZ

Biotechnology

Healthcare
$5.54 +16.75%

+$1.06 today

Market cap
$51.42M
Beta
2.66
P/E (TTM)
-6.5
EPS (TTM)
-$1.14
52W Low $6.33High $18.40

Volume 0.01M

Average 0.01M

Balance Sheet

Inspect the capital base behind the business.

Assets

$5.97M

FY 2025 · Annual

-54.2% YoY

Liabilities

$2.57M

FY 2025 · Annual

-1.5% YoY

Equity

$3.40M

FY 2025 · Annual

-67.4% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents547.81K558.57K66.53K9.72M3.04M
Short-term Investments00000
Net Receivables468.35K809.53K882.32K737.28K517.36K
Inventory00000
Other Current Assets30.19K101.14K264.76K363.79K382.89K
Total Current Assets1.05M1.47M1.21M10.82M3.94M
Property, Plant & Equipment (Net)1.3M1.22M2.34M2.21M2.21M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets0000(176.77K)
Total Non-current Assets1.3M1.22M2.34M2.21M2.03M
Total Assets2.35M2.69M3.56M13.03M5.97M
Account Payables267.3K385.8K702.91K924.25K1.24M
Short-term Debt00000
Tax Payables063.56K42.27K00
Deferred Revenue00000
Other Current Liabilities001M00
Total Current Liabilities400.78K634.36K2.42M1.33M1.57M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)161.11K215K140.7K00
Other Non-current Liabilities000123.58K90.37K
Total Non-current Liabilities748.25K678.77K1.53M1.28M1.01M
Total Liabilities1.15M1.31M3.94M2.61M2.57M
Common Stock126688
Retained Earnings(2.65M)(4.05M)(6.08M)(11.95M)(21.1M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity1.2M1.37M(384.32K)10.42M3.4M
Total Debt720.63K608.77K1.61M1.39M1.24M
Net Debt172.82K50.2K1.55M(8.33M)(1.8M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$1.4M
Receivables$302.9K
Other Current$342.5K
Total Current Assets$2.1M
PP&E (Net)$1.8M
Other Non-current$105.2K
Total Non-current Assets$1.9M
Total Assets$4.0M

Analysis

Selected assets total $4.0M for Latest. The largest visible component is PP&E (Net) at $1.8M, about 45.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportSep 18, 2026
4Statement of changes in beneficial ownershipSep 17, 2026
4Statement of changes in beneficial ownershipSep 2, 2026
4Statement of changes in beneficial ownershipAug 25, 2026
4Statement of changes in beneficial ownershipAug 25, 2026

How much cash does EXOZ have?

eXoZymes, Inc. (EXOZ) reported $3.04M in cash and equivalents in fiscal 2025.

How much debt does EXOZ carry?

eXoZymes, Inc. (EXOZ) reported $1.24M of total debt, with net debt of -$1.80M.